Clinical Trial Update: Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 study evaluating combination chemotherapy in young patients with relapsed or refractory acute lymphoblastic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Leukemia | Phase 3 | Status: COMPLETED